Digital coaching may solve the GLP-1 weight regain problem
NCT ID NCT07701460
First seen Jul 14, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study tests whether a digital lifestyle program (Noom®) can help adults maintain weight loss after stopping GLP-1 medications like semaglutide. Participants who recently stopped a GLP-1 are randomly assigned to the digital program or usual care, and weight is tracked remotely for 12 months. The goal is to find an affordable, accessible way to support long-term weight maintenance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a digital behavioral application called Noom® that provides strategies for weight maintenance
- What this could lead to
- If successful, this could show that a low-cost digital program helps people keep weight off after stopping GLP-1 medications.
- What could go wrong
- This is a relatively small, early-stage study, and results may not apply to everyone. The digital program may not be effective for all participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT MAINTENANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
This study is conducted remotely
Boston, Massachusetts, 02111, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.